Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01428492
Title Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Scottsdale Arizona 85259 United States Details
Novartis Investigative Site Duarte California 91010 United States Details
Novartis Investigative Site Atlanta Georgia 30322 United States Details
Novartis Investigative Site Chicago Illinois 60637 United States Details
Novartis Investigative Site New York New York 10029 United States Details
Novartis Investigative Site Chapel Hill North Carolina 27599-7305 United States Details
Novartis Investigative Site Columbus Ohio 43210 United States Details
Novartis Investigative Site Madison Wisconsin 53792 United States Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Vancouver British Columbia V5Z 1M9 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Galway Ireland Details
Novartis Investigative Site Taipei 100 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field